For the treatment of Selenium-tocopherol deficiency syndrome (white muscle disease) in weanling calves and breeding beef cattle.
LEARN MOREFor the treatment of dogs with clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood.
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MORE